PREVALENCE OF NAFLD, ADVANCED FIBROSIS, CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN PROSPECTIVELY ASSESSED PATIENTS WITH TYPE 2 DIABETES: A PROSPECTIVE STUDY

Conference Reports for NATAP

The Liver Meeting
Digital Experience
AASLD
Washington on 04-08
November 2022


PREVALENCE OF NAFLD, ADVANCED FIBROSIS, CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN PROSPECTIVELY ASSESSED PATIENTS WITH TYPE 2 DIABETES: A PROSPECTIVE STUDY

	AASLD 2022 nov 4-8